Tyson Halsey, CFA Managing Member, Income Growth Advisors, LLC Established Income Growth Advisors, LLC in 2011 to leverage off the strength of the growing income streams in MLP investment sector and 13 year investment record in MLPs. Founded Halsey Advisory and Management in 1999. Firm invested in Technology, Master Limited Partnerships, Quantitative Mutual Funds strategies, and a hedge fund. Worked as a Director at Elliot Davis Investment Advisors and Managing Director at Polaris Partners in South Carolina. Conferred CFA designation in 1993. Won the 1992 USA Today CNBC Investment Challenge in the options division. Worked at Alex Brown as institutional and Corporate Executive Services broker throughout 1990s. Worked in NYC until 2008 and relocated to Charleston SC.
The Clinically Sound Investor is a pharmacist with a PharmD and a BA in psychology. He has worked across the spectrum from very small independent and hospital pharmacies to the some of the largest retail corporations and medical centers in the nation, as well as experience in specialty and mail order settings. Fascinated by watching the rise of Walmart and Apple after 2008, he now follows the advice "know thyself" and puts expertise of understaning scientific literature to research biotechnology stocks. His investments early on were driven by binary events such as FDA Advisory Committee meetings and PDUFA dates (approvals). Despite initial successes, there were too few of these events, so he expanded into predicting Phase II/III trial results. His writings should not be considered financial advice or the basis for investment decisions. While his interpretations of clinical trial results--which may be overlooked or even thoroughly misunderstood by Wall Street--could be helpful, they're only as good as the original reports they come from. Although written by scientists and doctors, there will always be a slant from the sponsoring company, or worse (like, say, missing data...).
I have successfully passed the CFA level I Exam and I am a graduate student in Economics who has had extensive course work in finance, and mathematics. I have enjoyed watching the stock market since I was twelve years old.
Always looking for new opportunities. You can reach me at email@example.com
Southern born and raised . Married with two grown children . Like duck and deer hunting . Big LSU & New Orleans Saints fan . My best little bud when not at the deer camp is my French Bulldog , JAX . I am tired of brokers losing my money so now I do my own research and investing. My favorite stocks are :SDRL,MO,BBEP,VZ,T,VOD,GEL,SEP.AROW,EPD,SSEZY,XEL,BNS,BLX,O,OHI, and FCX .
I have a diverse background—as a financial journalist, resident physician, mixed martial artist, painter, entrepreneur, chemistry instructor and web developer—that enabled me to pioneer the “Integrated Investing Research” approach.
I provide consulting to clients, both the retail and professional investors. I accurately forecasted many clinical trials, such as the Flint Trials for Intercept, the Ascend Trials for InterMune and the Affinity Trials MannKind, just to name a few. Through Vincata Enterprises, LLC, I helped many clients to unlock substantial values for their investments.
As an expert in biopharmaceutical analysis, I am also more than capable of analyzing any other industries. Though not shown on Seeking Alpha, I have picked an aggregate basket of outperforming stocks.
Investing in biotech is highly risky, but it can be quite rewarding when investors have an edge in data analysis. Physicians who are rigidly scientific tend to lack the analytical prowess of financial experts. Conversely, financiers usually do not possess a physician’s medical expertise. Likewise, scientists are skillful in data analysis; yet they might not be familiar with a physician’s prescribing patterns, which is a requisite to successful biotech investing.
You can visit my website at https://www.retailinvestor360.com for business inquiry.
I currently work in the airline biz doing corporate real estate. I have a finance background, and worked as an analyst for a few years and before that I worked for a real estate developer. I have an MBA and write about macro trends and observations and will share predictions and investment ideas to take advantage of those predictions; as well as whatever else piques my interest.